Integrating cancer detection and SURgery Via molecular Imaging
The ambitious aim of this ERC-advanced grant proposal is to develop strategies that will connect cancer detection and surgery via tumor-specific molecular imaging techniques. This will lead to personalized patient-, or even tumor-...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
TAcTIC
TArgeTed molecular Imaging and surgery for gastro intestinal...
150K€
Cerrado
FG_WIT
AUTOMATED PROTOTYPE OF CANCER DETECTION FROM CTDNA
75K€
Cerrado
DPI2008-06691
TECNICAS PARA LA FUSION DE IMAGENES MR Y PET PARA LA LOCALIZ...
47K€
Cerrado
PRISAR2
proactive monitoring of cancer as an alternative to surgery
2M€
Cerrado
IMAGIO
IMAGING AND ADVANCED GUIDANCE FOR WORKFLOW OPTIMIZATION IN I...
37M€
Cerrado
DPI2016-77415-R
TRATAMIENTO PERSONALIZADO DEL CANCER DE MAMA POR DETERMINACI...
94K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The ambitious aim of this ERC-advanced grant proposal is to develop strategies that will connect cancer detection and surgery via tumor-specific molecular imaging techniques. This will lead to personalized patient-, or even tumor-specific treatment strategies. In addition, it will provide a tool for the selection of patients that, following preoperative (neoadjuvant) treatment, would benefit from additional (minimally invasive) surgery and identify patients who may be treated non-operatively. Fine-tuning the relation between tumor diagnosis, neoadjuvant treatment, preoperative planning and minimally invasive image-guided surgery will likely improve radical oncologic surgery while reducing surgical morbidity in cancer patients.
The mechanistic aim of the proposal is to develop an integrated multimodal imaging strategy that will more accurately connect tumor biology with surgical resection approaches via the use of tumor-specific molecular imaging agents. The cornerstone of this approach is the unique clinical translation of tumor-targeted imaging agents that are both radioactive (diagnostic imaging) and fluorescently (surgical guidance) labeled. It is expected that the proposed multimodal imaging agents will allow for a significant improvement of both imaging and surgery strategies.